Tirzepatide and semaglutide are both incretin-based medications that lower blood sugar and promote weight loss, but they work through different pathwayssemaglutide targets the GLP-1 receptor alone, while tirzepatide activates both GLP-1 and GIP receptors
As a result, these less-expensive weight loss drug alternatives remain available, though experts remain concerned about their safety and efficacy
Tirzepatide reduces appetite and promotes satiety as part of its mechanism for weight loss and glycaemic control
The time it takes to experience weight loss on semaglutide depends on the specific version of the medication, the person's baseline body weight, and other factors such as adherence to a healthy diet and exercise
At just 1.8mm thick, this film sits closely on your skin for optimal ingredient delivery
doi: 10.3389/fimmu.2021.6 272 TaylorE